Effects of Nigella orientalis and N. segetalis fixed oils on blood biochemistry in rats

Phytotherapy Research

Volumn 20, Issue 1, 2006, Pages 71-75

  Kokdil G ^a   Tamer, L ^a   Ercan, B ^a   Celik M ^b   Atik, U ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Biochemical parameters; Fixed oil; N. segetalis; Nigella orientalis; Oxidant antioxidant balance

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ESSENTIAL OIL; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NIGELLA ORIENTALIS EXTRACT; NIGELLA SEGETALIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; UREA; URIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; WATER;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; HEMATOCRIT; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NIGELLA; NIGELLA ORIENTALIS; NIGELLA SEGETALIS; NONHUMAN; RAT; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; BILIRUBIN; BLOOD CHEMICAL ANALYSIS; BLOOD UREA NITROGEN; ENZYMES; HEMATOLOGIC TESTS; LIPIDS; LIVER; MALONDIALDEHYDE; NIGELLA; PLANT EXTRACTS; PLANT OILS; PLANTS, MEDICINAL; RANDOM ALLOCATION; RATS; RATS, INBRED WKY; SERUM ALBUMIN; UREA; URIC ACID;

ANIMALIA; NIGELLA;

EID: 31644451644     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1809     Document Type: Article

References (29)

1. Akçasu A, Kavalali G. 1990. The fatty acids of N. damascena L. seed oil. Acta Pharm Turcica 32: 41-43.
2. Ali BH, Blunden G. 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17: 299-305.
3. Al-Hader A, Aqel M, Hasan Z. 1993. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int J Pharmacog 31: 96-100.
4. Al-Jishi SA, Abuo Hozaifa B. 2003. Effect of Nigella sativa on blood hemostatic function in rats. J Ethnopharmacol 85: 7-14.
5. Baytop T. 1999. Therapy with Medicinal Plants in Turkey. Nobel Tip Kitabevleri, İstanbul, 189.
6. Burits M, Bucar F. 2000. Antioxidant activity of Nigella sativa essential oil. Phytother Res 14: 323-328.
7. Davis PH. 1978. Flora of Turkey and the East Aegean Islands. Vol. 6. The Edinburgh University Press: Edinburgh, 98.
8. Davis PH. 1988. Flora of Turkey and the East Aegean Islands. Vol. 10. The Edinburgh University Press: Edinburgh, 294, 405-406.
9. EI-Dakhakny M, Mady NI, Halim MA. 2000. Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneitmittelforsch 50: 832-836.
10. El-Daly ES. 1998. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin induced toxicity in rats. J Pharm Belg 53: 87-95.
11. El-Kamali HH, Ahmed AH, Mohammed AAM. 1998. Antibacterial properties of essential oils from Nigella sativa seeds, Cymbopogon citratus leaves and Pulicaria undulata aerial parts. Fitoterapia 69: 77-78.
12. El-Tahir KEH, Ashour MMS, Al-Harbi MM. 1993. The respiratory effects of the volatile oil of the black seed (Nigella sativa) in guinea pigs: elucidation of the mechanism(s) of action. Gen Pharmacol 24: 1115-1122.
13. Hegnauer R. 1973. Chemotaxonomie der Pflanzen. Birkhauser Verlag: Basel and Stutgart, 43.
14. Houghton PJ, Zarka R. 1995. Fixed oil of N. sativa and derived thymoquinone inhibit eicosanoid generation in leucocytes and membrane lipid peroxidation. Planta Med 61: 33-36.
15. 4-treated rats. J Vet Med A 50: 264-268.
16. Kaya S. 2002. The effects of black cumin (Nigella sativa) seeds on CD3+, CD4+, CD8+ cells other leucocytes of immune system in human. Master thesis, Y.Y.U. Institute of Health Sciences, Van, Turkey.
17. Khanna T, Zaidi FA, Dandiya PC. 1993. CNS and analgesic studies on Nigella sativa. Fitoterapia 64: 407-410.
18. Meral U, Yener Z, Kahraman T, Mert N. 2001. Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits. J Vet Med A 48: 593-599.
19. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84: 407-412.
20. Nergiz C, Ötleş S. 1993. Chemical composition of Nigella sativa L. seeds. Food Chem 48: 259-261.
21. Rifai N, Bacharik PS, Albers II. 1999. Lipids, lipoproteins and apolipoproteins. In Tietz Textbook of Clinical Chemistry, Burtis CA, Ashwood ER (eds). Saunders: Philadelphia, 809-861.
22. Salomi NJ, Nair SC, Jawardhanan KK. 1992. Antitumor principles from Nigella sativa seeds. Cancer Lett 63: 41-46.
23. Şener B, Kusmenoǧlu Ş, Mutlugil A, Bingöl F. 1985. A study with seed oil of N. sativa. J Fac Pharm Gazi 2: 1-7.
24. Suboh SM, Bilto YY, Aburjai TA. 2004. Protective effects of selected medicinal plants against protein degradation, lipid peroxidation and deformability loss of oxidatively stressed human erythrocytes. Phytother Res 18: 280-284.
25. Swamy SMK, Tan, BKH. 2000. Cytotoxic and immuno-potentiating effects of ethanolic extract of N. sativa L. seeds. J Ethnopharmacol 70: 1-7.
26. Swamy SMK, Tan BKH. 2001. Extraction, isolation and characterization of antitumor principle, α-hederin from the seeds of Nigella sativa. Planta Med 67: 29-32.
27. Türker L, Bayrak A. 1997. Çörek otu (Nigella sativa L)'nun sabit ve uçucu yaǧ kompozisyonunun araştirilmasi. Standard 430: 128-137.
28. Yagi K. 1994. Lipid peroxides and related radicals in clinical medicine. In Free Radicals in Diagnostic Medicine, Armstrong D (ed.). Plenum Press: New York, 1-15.
29. Zaoui A, Cherrah Y, Alaoui K, Mahassine N, Amarouch H, Hassar M. 2002. Effects of Nigella sativa fixed oil on blood homeostasis in rat. J Ethnopharmacol 79: 23-26.